Free Trial
NASDAQ:BLACR

Bellevue Life Sciences Acquisition (BLACR) Stock Price, News & Analysis

$0.16 +0.02 (+14.85%)
As of 01/17/2025 10:03 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Bellevue Life Sciences Acquisition Stock (NASDAQ:BLACR)

Key Stats

Today's Range
$0.16
$0.16
50-Day Range
$0.11
$0.16
52-Week Range
$0.09
$0.20
Volume
1,400 shs
Average Volume
8,775 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Receive BLACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BLACR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BLACR Stock Analysis - Frequently Asked Questions

Bellevue Life Sciences Acquisition's stock was trading at $0.13 at the start of the year. Since then, BLACR stock has increased by 20.8% and is now trading at $0.1570.
View the best growth stocks for 2025 here
.

Shares of BLACR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
--
Industry
-
Sub-Industry
N/A
Current Symbol
NASDAQ:BLACR
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:BLACR) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners